STAT+ Healthcare Personnel Changes
- Inozyme Pharma has announced the promotion of Petra Duda to chief medical officer.
- before joining Inozyme Pharma last year, duda served as vice president and global development lead at UCB, bringing a wealth of experience in pharmaceutical leadership and clinical advancement...
Petra Duda has been promoted to chief medical officer at Inozyme Pharma, a pivotal move for teh company. This appointment elevates Duda from her previous role as senior vice president of clinical development, showcasing her significant contributions and the company’s confidence in her leadership. Duda’s background includes a crucial global development lead position at UCB, bringing extensive experience in pharmaceutical leadership and clinical advancement. This strategic shift is poised to bolster Inozyme Pharma’s future initiatives. You’ll find compelling reports on personnel moves like this at News directory 3. what strategic directions will Duda shepherd Inozyme Pharma toward? Discover what’s next.
Inozyme Pharma names Petra Duda Chief Medical Officer
Updated May 26, 2025
Inozyme Pharma has announced the promotion of Petra Duda to chief medical officer. Duda previously held the position of senior vice president of clinical development at the company.
before joining Inozyme Pharma last year, duda served as vice president and global development lead at UCB, bringing a wealth of experience in pharmaceutical leadership and clinical advancement to her new role as chief medical officer.